The United States Food and Drug Administration has renewed its scrutiny into Yasmin, Yaz and other birth control pills with newer formulations, warning that these may increase the risk for blood clots. The new investigation was ordered when a federal judge in Illinois who is overseeing a consolidation of Yaz cases unsealed on Dec. 5 several court documents that suggested Bayer may have withheld data from FDA about the blood clots risks of its drugs.
Yasmin Side Effects: Blood Clots? Yasmin, Yaz and other birth control pills with newer formulations may increase the risk for blood clots, safety regulators in both the United States and Canada warned separately this week. These oral contraceptives, which use a synthetic formulation of the female hormones drospirenone and ethinyl estradiol are now under the U.S. Food and Drug Administration’s renewed scrutiny, following research that suggests these pills are more likely to cause blood clots […]